Press Releases

PrecisionLife strengthens leadership team with appointments of Dr Pradip Banerjee and Dr Kam Pooni

PrecisionLife, a leader in AI-driven precision medicine for chronic diseases, today announced the appointments of Dr Pradip Banerjee, PhD, MBA, as an Independent Non-Executive Director and Dr Kam Pooni, PhD, as Chief Product Officer. These strategic hires further strengthen the company’s leadership as it scales from a pioneering technology innovator to a commercial organization delivering real-world healthcare impact.

Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration

CRDMO successfully scaled and transferred Renaissance Pharma’s lead candidate, Daretabart a humanized monoclonal antibody targeting GD2 for high-risk neuroblastoma, in just 9 months.

CellCarta and Sonic Healthcare Establish Strategic Partnership to Commercialize Companion Diagnostics Through Lab Network

CellCarta has announced a Strategic Partnership with Sonic to launch the first commercial laboratory relationship in CellCarta’s Lab Network strategy.

ClearNote Health Secures $52 Million in Series D Financing and Strengthens Leadership Team to Accelerate Growth in Early Cancer Detection

ClearNote Health today announced a $52M Series D financing alongside the appointment of Kevin Keegan as President and COO.

DNAnexus Scales AI-Driven Capabilities : 17-Year Multiomics Pioneer Powers Next Era of Precision Health

DNAnexus signals a bold new chapter in AI-powered precision health with several new product innovations and solution packages that extend its position as the purpose-built platform where the world's most scientifically complex data becomes the world's most powerful AI fuel.

Baptist Health South Florida and The START Center for Cancer Research Announce Strategic Partnership to Expand Patient Access to Early-Phase Cancer Trials

New START site to be established in collaboration with Baptist Health Herbert Wertheim Cancer Institute will bring novel oncology therapies closer to patients across South Florida.

‘Biopharma innovators must widen CDMO networks to accelerate development’ says Shilpa Biologicals CEO ahead of BIO San Diego

Ahead of BIO San Diego, Shilpa Biologicals urges biotech innovators to engage CDMO partners earlier and look beyond large-scale providers. Over-relying on a narrow network of large CDMOs increases the risk of scope creep, severe clinical trial delays, and budget overruns of up to 40%. Conversely, incorporating smaller CDMOs can lower costs and accelerate timelines from discovery to clinic by several months.

Ambience Healthcare Expands Chart-Aware Intelligence to Full Inpatient Workflow

Building on its chart awareness platform, Ambience now delivers clinical context across the full hospital stay, from admission through discharge

Neuland reports record quarterly revenue of $83M* driven by commercial NCE projects

Quarterly revenue growth up 135% year-on-year, with total revenues passing ₹2000 crore for the first time

Leica Biosystems and CellCarta Expand Collaborative Companion Diagnostic Development Model to Accelerate Commercialization Globally

CellCarta and Leica Biosystems have announced a strategic partnership to bring a proven companion diagnostic (CDx) joint development model from China to biopharma sponsors globally.

Pfizer and Innovent Biologics Enter $10.5 Billion Oncology Drug Development Partnership for 12 Cancer Programs

Pfizer and Innovent Biologics have formed a major oncology partnership worth up to $10.5 billion to develop 12 cancer treatment programs, including antibody-drug conjugates (ADCs) and multispecific antibodies. Pfizer will pay $650 million upfront, with additional milestone-based payments tied to development and commercialization progress. The collaboration combines Innovent’s early-stage research capabilities with Pfizer’s global development and commercialization expertise, aiming to accelerate the delivery of innovative cancer therapies worldwide.

Yourgene Health Launches Insight DPYD Assay

Enhanced pharmacogenetic workflow includes additional variants to support safer, personalised chemotherapy treatment for cancer patients

NGI Becomes First Certified Core Lab and Service Provider for Epigenica’s EpiFinder™ Platforms

Epigenica AB has announced an agreement with the National Genomics Infrastructure, one of the largest technical platforms at SciLifeLab.

Medix Biochemica Announces $5 Million Investment to Expand Recombinant Antigen Capabilities

Medix Biochemica has announced a Board-approved $5 million investment to expand its recombinant antigen and cell culture technology capabilities across its Espoo, Finland and St. Louis, Missouri facilities.

Patients benefit as the Royal Hospital for Neuro-disability introduces innovative predictive technology to support earlier recognition of infection risk

eClinical Solutions and Hobson & Company Quantify Financial and Operational Value of a Clinical Data Intelligence Platform for Clinical Trials

Bringing price transparency to clinical trial technology investment and return, company unveils ROI calculator for pharmaceutical companies and CROs

VisualDx and Perplexity Bring Clinician-Trusted Medical Imagery into Generative AI

START Research Expands Clinical Leadership with Appointment of Dr. Neel Belani as Clinical Investigator at START New Jersey

Strengthening clinical research capabilities in one of the nation’s most densely populated and high-opportunity oncology markets

Revecore Launches AI-Powered Underpayment Recovery and Denial Appeals Capabilities

Axithra Appoints Lars Kongsbak as CEO to Lead Next Phase of Growth and Series A Financing

Axithra today announced the appointment of Lars Kongsbak as Chief Executive Officer.